SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 217 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.

Quarter-by-quarter ownership
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$5,000
-28.6%
1500.0%0.00%
-50.0%
Q4 2017$7,000
-12.5%
1500.0%0.00%
-33.3%
Q3 2017$8,0001500.00%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 228,873$7,475,0004.17%
PFM Health Sciences, LP 5,326,671$173,969,0003.54%
Marcus Capital, LLC 22,950$750,0002.76%
Partner Investment Management, L.P. 72,284$2,361,0002.55%
CADIAN CAPITAL MANAGEMENT, LP 1,240,944$40,529,0002.19%
HARVEY CAPITAL MANAGEMENT INC 158,580$5,179,0001.94%
SECTORAL ASSET MANAGEMENT INC 498,412$16,278,0001.78%
Everett Capital Advisors UK LLP 551,173$18,001,0001.52%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 125,210$4,089,0001.46%
Atika Capital Management LLC 113,000$3,691,0001.26%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders